Market Overview
Genotyping is the process of examining a person's DNA sequence. The genetic variations can be examined through biological assays and in comparison, to the development of other people. Genetic anomalies like single nucleotide polymorphisms and major structural alterations in DNA can be studied using genotyping. Genotyping of microorganisms, such as bacteria and viruses, can assist identify a person's parentage.
Report Analysis
According to the research report, “Genotyping Market: Current Analysis And Forecast (2021-2027)” asserts that the Genotyping Market is driven due to the increasing prevalence of genetic diseases in leading economies globally during the forecasted period of 2021-2027. In the years to come, growing government financing for initiatives like genome research may also present significant revenue-generating potential for top market players. Additional causes such as the increased number of people with diabetes and other chronic illnesses will boost the genotyping market in the future.
Segmentation
- By Product or Services
On the basis of products or services, the Genotyping Market is categorized into Reagents & kits, Genotyping services, Instruments, and Bioinformatics. Due to the rising demand for reagents, samples, and kits used in the genome sequencing process, the reagent and kits segment had a considerable increase in 2020. However, it is anticipated that the bioinformatics market would experience profitable growth during the projected period as a result of the rising demand for better and more advanced systems and solutions in the healthcare and diagnostic industries to store patient genetic data.
- By Technology
The Genotyping Market in terms of technology constitutes PCR, Sequencing, Electrophoresis, Microarray, and Others. In 2020, the genotyping market saw a significant market share for PCR. This is primarily caused by the population's fast-rising incidence of genetic illnesses and the ongoing development of the infrastructure for medical diagnostics brought on by the growth of the PCR segment. Due to ongoing improvements in sequencing technology and rising investments in biotechnology, it is also anticipated that throughout the projection period, the sequencing segment will account for a sizeable portion of the genotyping market.
- By End-Users
In terms of end-users, the Genotyping Market includes Pharmaceutical & Biotechnology companies, Hospitals & Clinics, Academic & Government Institutes, Diagnostic & Research Institutions, and Others. The pharmaceutical and biotechnology industries will have a sizable portion of the market. The segmental rise in 2020 is mostly attributable to the growing requirement for pharmacogenomics in the medication development process and the rising demand for certain treatments. The genotyping market is expected to experience considerable expansion during the projected period, particularly in the diagnostic and research institution segment.
Key Players
Some major key players in the Genotyping Market are:
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Agilent Technologies
- Eurofins Scientific Inc.
- Illumina Inc.
- Qiagen Inc.
- GE Healthcare Inc.
- Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Thermo Fisher Scientific Inc.
- Others
Regional Analysis
Based on the regional analysis, the Genotyping Market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America will hold the biggest market share because of the region's increased use of technologically sophisticated products, the presence of significant pharmaceutical and biopharmaceutical businesses, proactive government policies, and improvements in healthcare infrastructure. Another important element contributing to the high market share in this area is the existence of big players.
Future Outlook
Over the impending years, the Genotyping Market will have rapid growth during the anticipated period because of technological developments and DNA sequencing's falling costs. In the years ahead, the market expansion is anticipated to be aided by factors such as the rising prevalence of genetic illnesses, increased interest in personalized medicine, expanding significance of genotyping in drug development, and rising need for bioinformatics tools for data analysis.
For More Information on the Research Report, refer to below links: –
Global Genotyping Market Analysis
Related Report: -
Contact Us: -
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
